Pyrroles and other heterocycles as inhibitors of p38 kinase.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Bioorganic & Medicinal Chemistry Letters

• Publication date

  1998-10-06

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0960-894X(98)00495-8PMID 9873604
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Novel homologues of CSBP/p38 MAP kinase: activation, substrate specificity and sensitivity to inhibition by pyridinyl imidazoles.

  1997cited by this paper
• p38-2, a Novel Mitogen-activated Protein Kinase with Distinct Properties*

  1997cited by this paper
• Activation of the novel stress‐activated protein kinase SAPK4 by cytokines and cellular stresses is mediated by SKK3 (MKK6); comparison of its substrate specificity with that of other SAP kinases

  1997cited by this paper
• Kinetic mechanism for p38 MAP kinase.

  1997cited by this paper
• ERK6, a mitogen-activated protein kinase involved in C2C12 myoblast differentiation.

  1996cited by this paper
• 1-substituted 4-aryl-5-pyridinylimidazoles: a new class of cytokine suppressive drugs with low 5-lipoxygenase and cyclooxygenase inhibitory potency.

  1996cited by this paper
• Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function.

  1996cited by this paper
• 2,4,5- triarylimidazole inhibitors of IL-1 biosynthesis

  1995cited by this paper
• Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis.

  1994cited by this paper
• A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells.

  1994cited by this paper
• A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins.

  1994cited by this paper
• Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis

  1994cited by this paper
• Repeated therapy with monoclonal antibody to tumour necrosis factor α (cA2) in patients with rheumatoid arthritis

  1994cited by this paper
• Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis.

  1994cited by this paper
• A protein kinase involved in the regulation of inflammatory cytokine biosynthesis

  1994cited by this paper
• The Anion of 4-Dimethoxymethylpyridine. A Convenient Synthesis of Some 4-Pyridyl Ketones A convienient synthesis of some 4-pyridyl ketones

  1993cited by this paper
• Bicyclic Imidazoles as a Novel Class of Cytokine Biosynthesis Inhibitors

  1993cited by this paper
• Dissociation of IL-1 beta synthesis and secretion in human blood monocytes stimulated with bacterial cell wall products.

  1993cited by this paper
• Inflammatory cytokines: interleukin-1 and tumor necrosis factor as effector molecules in autoimmune diseases.

  1991cited by this paper
• Radiologic analysis of arthritis in rats after systemic injection of streptococcal cell walls.

  1979cited by this paper

• Non-fused Pyrimidine Derivatives as Potential Pharmacological Entities: A Review.

  2024cites this paper
• Paal–Knorr Pyrrole Synthesis

  2021cites this paper
• Highly Functionalized Pyrrolylpyridines from 2-(Acylethynyl)-pyrroles

  2020cites this paper
• A Review on Solvent-free Methods in Organic Synthesis

  2020cites this paper
• 3-Methyl-4,5-dihydro-1H-pyrazol-5-one Adduct with 1,4-Diphenylbut-2-ene-1,4-dione in Reactions with Primary Amines

  2020cites this paper
• Nitroalkenes as Latent 1,2-Biselectrophiles - A Multicatalytic Approach for the Synthesis of 1,4-Diketones and Their Application in a Four-Step One-Pot Reaction to Polysubstituted Pyrroles.

  2017cites this paper
• Slack sodium-activated potassium channel membrane expression requires p38 mitogen-activated protein kinase phosphorylation.

  2016cites this paper
• Anti-arthritic agents: progress and potential.

  2015cites this paper
• Comparison of (bio-)transformation methods for the generation of metabolite-like compound libraries of p38α MAP kinase inhibitors using high-resolution screening.

  2014cites this paper
• Chalcones as Versatile Synthons for the Synthesis of 5- and 6-Membered Nitrogen Heterocycles

  2014cites this paper
• Preventing MEK1 activation influences the responses of human osteosarcoma cells to bone morphogenetic proteins 2 and 9

  2013cites this paper
• p38 Mitogen-activated protein kinase inhibitors: a review on pharmacophore mapping and QSAR studies.

  2013cites this paper
• Design, synthesis, and biological evaluation of novel disubstituted dibenzosuberones as highly potent and selective inhibitors of p38 mitogen activated protein kinase.

  2012cites this paper
• Adduct of dimedone and 1,2-dibenzoylethene in reactions with nitrogen binucleophiles

  2012cites this paper
• Preparation of NH‐Pyrroles under Superelectrophilic Conditions by an Aza‐Nazarov Reaction Cascade with Indole as Neutral Leaving Group: Experiment and Theory

  2012cites this paper
• Virtual screening using a conformationally flexible target protein: models for ligand binding to p38α MAPK

  2012cites this paper
• Integrated Analytical Strategies for Drug Discovery

  2011cites this paper
• Medicinal Chemistry Approaches for the Inhibition of the p38 MAPK Pathway

  2011cites this paper
• Apicomplexa, trypanosoma and parasitic nematode protein kinases as antiparasitic therapeutic targets.

  2010cites this paper
• Development of an online p38α mitogen-activated protein kinase binding assay and integration of LC–HR-MS

  2010cites this paper
• Triethanolamine-mediated palladium-catalyzed regioselective C-2 direct arylation of free NH-pyrroles.

  2010cites this paper
• Protein Kinase Inhibitors in Drug Discovery

  2010cites this paper
• Role of the hydrogen bonding heteroatom-Lys53 interaction between the p38alpha mitogen-activated protein (MAP) kinase and pyridinyl-substituted 5-membered heterocyclic ring inhibitors.

  2009cites this paper
• Silibinin induces protective superoxide generation in human breast cancer MCF-7 cells

  2009influential citation
• Chapter 2 Pyrazol-3-ones. Part IV: Synthesis and Applications

  2009cites this paper
• Paal–Knorr furan synthesis

  2009cites this paper
• Leptin regulates tau phosphorylation and amyloid through AMPK in neuronal cells.

  2009cites this paper
• 4-[2-(4-Fluorophenyl)-1H-pyrrol-3-yl]pyridine

  2009cites this paper
• Tetrahydropyridine derivatives with inhibitory activity on the production of proinflammatory cytokines: part 1.

  2009cites this paper
• Microwave-assisted synthesis of pyridylpyrroles from N-acylated amino acids

  2009cites this paper
• Cyclocondensation of alpha-aminonitriles and enones: a short access to 3,4-dihydro-2H-pyrrole 2-carbonitriles and 2,3,5-trisubstituted pyrroles.

  2009cites this paper
• SD0006: A Potent, Selective and Orally Available Inhibitor of p38 Kinase

  2009cites this paper
• Solvent-free synthesis of penta-substituted pyrroles: one-pot reaction of amine, alkyl acetoacetate, and fumaryl chloride

  2009cites this paper
• Untersuchung von p38α MAP-Kinase/Inhibitor-Komplexen in Lösung mittels Kernresonanzspektroskopie

  2008cites this paper
• Synthesis and biological evaluation of novel 2,4,5-triaryl-1H-pyrazol-3(2H)-ones as inhibitors of ALK5

  2008cites this paper
• Pharmacophore modeling of diverse classes of p38 MAP kinase inhibitors.

  2008cites this paper
• A synthesis of 5-hetaryl-3-(2-hydroxybenzoyl)pyrroles

  2008cites this paper
• Highly regioselective synthesis of polysubstituted pyrroles through three-component reaction induced by low-valent titanium reagent.

  2008cites this paper
• ATLAS—A High-Throughput Affinity-Based Screening Technology for Soluble Proteins: Technology Application Using p38 MAP Kinase

  2008cites this paper
• Effect of the distal C162S mutation on the energetics of drug binding to p38alpha MAP kinase.

  2008cites this paper
• 4-(4-Fluorophenyl)-2-methyl-3-(1-oxy-4-pyridyl)isoxazol-5(2H)-one

  2008cites this paper
• Novel therapeutic targets for the treatment of tubulointerstitial fibrosis

  2008cites this paper
• Are MAP Kinases Drug Targets? Yes, but Difficult Ones

  2007cites this paper
• Signaling through RAS-RAF-MEK-ERK: from basics to bedside.

  2007cites this paper
• Target validation in drug discovery.

  2007cites this paper
• Role of NF-kappaB in transcriptional regulation of the phagocyte NADPH oxidase by tumor necrosis factor-alpha.

  2007cites this paper
• 4-[4-(4-Fluorophenyl)-2-methyl-5-oxo-2,5-dihydroisoxazol-3-yl]-1-methylpyridinium iodide–4-[3-(4-fluorophenyl)-2-methyl-5-oxo-2,5-dihydroisoxazol-4-yl]-1-methylpyridinium iodide (0.6/0.4)

  2007cites this paper
• Role of NF‐κB in transcriptional regulation of the phagocyte NADPH oxidase by tumor necrosis factor‐α

  2007cites this paper
• PROGRESS IN ACHIEVING PROOF OF CONCEPT FOR p38 KINASE INHIBITORS

  2007cites this paper
• Synthesis and biological activity of vicinal diaryl-substituted 1H-imidazoles

  2007cites this paper
• Anticoccidial kinase inhibitors: identification of protein kinase targets secondary to cGMP-dependent protein kinase.

  2006cites this paper
• Signal transduction therapy with rationally designed kinase inhibitors

  2006cites this paper
• New approaches to the treatment of inflammatory disorders small molecule inhibitors of p38 MAP kinase.

  2006cites this paper
• Identification of Small Signalling Molecules Promoting Cardiac-Specific Differentiation of Mouse Embryonic Stem Cells

  2006cites this paper
• Synthesis and Biological Activity of Pyrrole, Pyrroline and Pyrrolidine Derivatives with Two Aryl Groups on Adjacent Positions

  2006cites this paper
• Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes.

  2006cites this paper
• Racemic and chiral sulfoxides as potential prodrugs of 4-pyrone COX-2 inhibitors.

  2006cites this paper
• Inhibitors of casein kinase 1 block the growth of Leishmania major promastigotes in vitro.

  2006cites this paper
• Small molecular anti‐cytokine agents

  2006influential citation
• Substituted Isoxazoles as Potent Inhibitors of p38 MAP Kinase

  2006cites this paper
• The proinflammatory cytokines IL-1β and TNF-α induce the expression of Synoviolin, an E3 ubiquitin ligase, in mouse synovial fibroblasts via the Erk1/2-ETS1 pathway

  2006influential citation
• Convergent synthesis of 2,3-bisarylpyrazolones through cyclization of bisacylated pyrazolidines and hydrazines

  2006cites this paper
• Synthesis and SAR of 2,3-diarylpyrrole inhibitors of parasite cGMP-dependent protein kinase as novel anticoccidial agents.

  2005cites this paper
• The discovery of novel chemotypes of p38 kinase inhibitors.

  2005cites this paper
• Construction of 4D-QSAR Models for Use in the Design of Novel p38-MAPK Inhibitors

  2005cites this paper
• P38 MAP kinase inhibitors: evolution of imidazole-based and pyrido-pyrimidin-2-one lead classes.

  2005cites this paper
• The development of new isoxazolone based inhibitors of tumor necrosis factor-alpha (TNF-alpha) production.

  2005cites this paper
• Pyrazolones as therapeutics for kinase-mediated inflammatory disorders

  2005cites this paper
• R-130823, a novel inhibitor of p38 MAPK, ameliorates hyperalgesia and swelling in arthritis models.

  2005cites this paper
• The development of monocyclic pyrazolone based cytokine synthesis inhibitors.

  2005cites this paper
• Hydroxylated N-alkyl-4-piperidinyl-2,3-diarylpyrrole derivatives as potent broad-spectrum anticoccidial agents.

  2005cites this paper
• Structure-activity relationships of p38 mitogen-activated protein kinase inhibitors.

  2005cites this paper
• Nitrofen induces a redox-dependent apoptosis associated with increased p38 activity in P19 teratocarcinoma cells.

  2005cites this paper
• Topoisomerase II and histone deacetylase inhibitors delay the G2/M transition by triggering the p38 MAPK checkpoint pathway

  2004cites this paper
• Kinomics-structural biology and chemogenomics of kinase inhibitors and targets.

  2004cites this paper
• A prodrug approach to COX-2 inhibitors with methylsulfone.

  2004cites this paper
• p38 mitogen-activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the rat.

  2004cites this paper
• Mycophenolic Acid Inhibits Platelet‐Derived Growth Factor‐Induced Reactive Oxygen Species and Mitogen‐Activated Protein Kinase Activation in Rat Vascular Smooth Muscle Cells

  2004cites this paper
• Benzimidazolone p38 inhibitors.

  2004cites this paper
• Characterization of pristane-induced arthritis, a murine model of chronic disease: response to antirheumatic agents, expression of joint cytokines, and immunopathology.

  2004cites this paper
• General facile synthesis of 2,5-diarylheteropentalenes

  2004cites this paper
• Indole-based heterocyclic inhibitors of p38alpha MAP kinase: designing a conformationally restricted analogue.

  2003cites this paper
• Kinases, homology models, and high throughput docking.

  2003cites this paper
• The development of new triazole based inhibitors of tumor necrosis factor-α (TNF-α) production

  2003cites this paper
• Novel substituted pyridinyl imidazoles as potent anticytokine agents with low activity against hepatic cytochrome P450 enzymes.

  2003cites this paper
• Rough Lipopolysaccharide from Brucella abortus and Escherichia coli Differentially Activates the Same Mitogen-Activated Protein Kinase Signaling Pathways for Tumor Necrosis Factor Alpha in RAW 264.7 Macrophage-Like Cells

  2002cites this paper
• Pyrazole urea-based inhibitors of p38 MAP kinase: from lead compound to clinical candidate.

  2002cites this paper
• In the Cellular Garden of Forking Paths: How p38 MAPKs Signal for Downstream Assistance

  2002cites this paper
• From imidazoles to pyrimidines: new inhibitors of cytokine release.

  2002cites this paper
• One-step synthesis of 3,5-disubstituted-2-pyridylpyrroles from the condensation of 1,3-diones and 2-(aminomethyl)pyridine.

  2002cites this paper
• Glucose‐dependent regulation of osteoclast H+‐ATPase expression: Potential role of p38 MAP‐kinase

  2002cites this paper
• Synthesis of Imidazo[2, 1‐a]phthalazines, Potential Inhibitors of p38 MAP Kinase. Prediction of Binding Affinities of Protein Ligands

  2002cites this paper
• Activation of the glucose transporter GLUT4 by insulin.

  2002cites this paper
• Pyridinyl-pyrimidine und -imidazole - Neue Hemmstoffe der Zytokinfreisetzung

  2002cites this paper
• Chapter 18. Inhibitors of p38α MAP kinase

  2002cites this paper
• p38 MAP kinase: molecular target for the inhibition of pro-inflammatory cytokines.

  2001cites this paper
• RECENT ADVANCES IN THE SYNTHESIS OF PYRROLES

  2001cites this paper
• The discovery of RPR 200765A, a p38 MAP kinase inhibitor displaying a good oral anti-arthritic efficacy.

  2001cites this paper
• IL‐1‐ and TNF‐induced bone resorption is mediated by p38 mitogen activated protein kinase *

  2001cites this paper
• Intracellular signaling pathways as a target for the treatment of rheumatoid arthritis.

  2001cites this paper